Nationwide trends in cardiac risk and mortality in patients with incident type 2 diabetes: A Danish cohort study
Diabetes Care Aug 16, 2021
Gyldenkerne C, Knudsen JS, Olesen KKW, et al. - Between 1996 and 2011, Danish patients with incident type 2 diabetes who had no prior cardiovascular disease experienced significant reductions in cardiac risk and mortality. The risk reductions were accompanied by an increase in the use of prophylactic cardiovascular medications.
In this population-based cohort study, 209,311 patients with incident diabetes were identified.
The 7-year risk of myocardial infarction decreased from 6.9 to 2.8%, cardiac death from 7.1 to 1.6%, and all-cause death from 28.9 to 16.8% from 1996–1999 to 2008–2011.
Compared with the general population, 7-year risk differences for myocardial infarction, cardiac death, and all-cause death fell from 3.3 to 0.8%, 2.7 to 0.5%, and 10.6 to 6.0%, respectively.
During the study period, the use of cardiovascular medications, particularly statins, increased within ± 1 year of a diabetes diagnosis.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries